Bioniche Life Sciences

bioniche.com
+1613966-8058

Bioniche Life Sciences Inc.

231 Dundas Street East
K8N 1E2 Belleville
Canada
+1613966-8058
bioniche.com
Profile Products News

About Bioniche Life Sciences

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 190 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health.

Read more about Bioniche Life Sciences
Facts about Bioniche Life Sciences
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Bioniche Life Sciences

Product portfolio

Show all

News about Bioniche Life Sciences

Bioniche Life Sciences

26-Nov-2009 | research and development

Bioniche Strengthens the International Patent Portfolio for its MCC Technology Platform

Japanese patent issuances facilitate commercialization of MCC in Japan

Read news
Bioniche Life Sciences

20-Aug-2008 | research and development

Bioniche Phase III Clinical Trial in Bladder Cancer Progressing Well

Bioniche Life Sciences Inc. announced that its first Phase III clinical trial with a formulation of Mycobacterial Cell Wall-DNA Complex (MCC), trademarked ...

Read news
Bioniche Life Sciences

12-Sep-2007 | research and development

Bioniche Reaches Special Protocol Assessment Agreement with U.S. FDA for Phase III Comparative Bladder Cancer Trial

Bioniche Life Sciences Inc. announced that an agreement has been reached with the U.S. Food and Drug Administration (FDA) under the Special Protocol ...

Read news
Bioniche Life Sciences

27-Aug-2007 | research and development

Bioniche Ships First Order of E. coli O157:H7 Cattle Vaccine

Bioniche Life Sciences Inc. announced that the first permit has been issued for its E. coli O157:H7 cattle vaccine, and that the first order of vaccine has ...

Read news
Bioniche Life Sciences

12-Dec-2006 | business & finance

Bioniche Completes Sale of Two Remaining Assets Associated with Irish Pharma Group

Bioniche Life Sciences Inc. announced that it has completed the sale of two of its remaining assets associated with Bioniche Pharma Holdings Limited, the ...

Read news
Bioniche Life Sciences

06-Nov-2006 | research and development

Bioniche Expands Patent Portfolio with Three New Patents

Patents cover human health technologies in U.S. and EU

Read news
Bioniche Life Sciences

08-May-2006 | research and development

U.S. FDA Grants Fast Track Designation for Bioniche Bladder Cancer Product

Bioniche Life Sciences Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the Company's proprietary ...

Read news
Bioniche Life Sciences

15-Mar-2006 | research and development

Bioniche Granted First Major Composition Patent for Oligonucleotide Technology

Bioniche Life Sciences Inc. announced that it has been granted a European patent (EP1432450) covering the composition and use of a novel oligonucleotide ...

Read news
Show more news about Bioniche Life Sciences

Here you will find Bioniche Life Sciences Inc.